SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001370053-20-000025
Filing Date
2020-05-06
Accepted
2020-05-06 16:10:58
Documents
15
Period of Report
2020-05-06
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K anab5620208k.htm   iXBRL 8-K 38796
2 EXHIBIT 99.1 q12020earningsrelease.htm EX-99.1 101911
  Complete submission text file 0001370053-20-000025.txt   298964

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anab-20200506.xsd EX-101.SCH 4450
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT anab-20200506_cal.xml EX-101.CAL 624
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anab-20200506_def.xml EX-101.DEF 1474
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT anab-20200506_lab.xml EX-101.LAB 27263
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anab-20200506_pre.xml EX-101.PRE 14114
15 EXTRACTED XBRL INSTANCE DOCUMENT anab5620208k_htm.xml XML 4460
Mailing Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Filer) CIK: 0001370053 (see all company filings)

IRS No.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37985 | Film No.: 20852712
SIC: 2834 Pharmaceutical Preparations